Table of Contents

2019-2024 Global Oncology Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Drugs Consumption 2014-2024
2.1.2 Oncology Drugs Consumption CAGR by Region
2.2 Oncology Drugs Segment by Type
2.2.1 Antimetabolite
2.2.2 Alkaloid drugs
2.2.3 Hormone
2.2.4 Targeted drug
2.2.5 Platinum-based drugs
2.2.6 Other
2.3 Oncology Drugs Consumption by Type
2.3.1 Global Oncology Drugs Consumption Market Share by Type (2014-2019)
2.3.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
2.3.3 Global Oncology Drugs Sale Price by Type (2014-2019)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other
2.5 Oncology Drugs Consumption by Application
2.5.1 Global Oncology Drugs Consumption Market Share by Application (2014-2019)
2.5.2 Global Oncology Drugs Value and Market Share by Application (2014-2019)
2.5.3 Global Oncology Drugs Sale Price by Application (2014-2019)

3 Global Oncology Drugs by Players
3.1 Global Oncology Drugs Sales Market Share by Players
3.1.1 Global Oncology Drugs Sales by Players (2017-2019)
3.1.2 Global Oncology Drugs Sales Market Share by Players (2017-2019)
3.2 Global Oncology Drugs Revenue Market Share by Players
3.2.1 Global Oncology Drugs Revenue by Players (2017-2019)
3.2.2 Global Oncology Drugs Revenue Market Share by Players (2017-2019)
3.3 Global Oncology Drugs Sale Price by Players
3.4 Global Oncology Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oncology Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oncology Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Oncology Drugs by Regions
4.1 Oncology Drugs by Regions
4.1.1 Global Oncology Drugs Consumption by Regions
4.1.2 Global Oncology Drugs Value by Regions
4.2 Americas Oncology Drugs Consumption Growth
4.3 APAC Oncology Drugs Consumption Growth
4.4 Europe Oncology Drugs Consumption Growth
4.5 Middle East and Africa Oncology Drugs Consumption Growth

5 Americas
5.1 Americas Oncology Drugs Consumption by Countries
5.1.1 Americas Oncology Drugs Consumption by Countries (2014-2019)
5.1.2 Americas Oncology Drugs Value by Countries (2014-2019)
5.2 Americas Oncology Drugs Consumption by Type
5.3 Americas Oncology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oncology Drugs Consumption by Countries
6.1.1 APAC Oncology Drugs Consumption by Countries (2014-2019)
6.1.2 APAC Oncology Drugs Value by Countries (2014-2019)
6.2 APAC Oncology Drugs Consumption by Type
6.3 APAC Oncology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oncology Drugs by Countries
7.1.1 Europe Oncology Drugs Consumption by Countries (2014-2019)
7.1.2 Europe Oncology Drugs Value by Countries (2014-2019)
7.2 Europe Oncology Drugs Consumption by Type
7.3 Europe Oncology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Oncology Drugs by Countries
8.1.1 Middle East and Africa Oncology Drugs Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Oncology Drugs Value by Countries (2014-2019)
8.2 Middle East and Africa Oncology Drugs Consumption by Type
8.3 Middle East and Africa Oncology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oncology Drugs Distributors
10.3 Oncology Drugs Customer

11 Global Oncology Drugs Market Forecast
11.1 Global Oncology Drugs Consumption Forecast (2019-2024)
11.2 Global Oncology Drugs Forecast by Regions
11.2.1 Global Oncology Drugs Forecast by Regions (2019-2024)
11.2.2 Global Oncology Drugs Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oncology Drugs Forecast by Type
11.8 Global Oncology Drugs Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Details
12.1.2 Oncology Drugs Product Offered
12.1.3 Roche Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Roche News
12.2 HENGRUI
12.2.1 Company Details
12.2.2 Oncology Drugs Product Offered
12.2.3 HENGRUI Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 HENGRUI News
12.3 AstraZeneca
12.3.1 Company Details
12.3.2 Oncology Drugs Product Offered
12.3.3 AstraZeneca Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 AstraZeneca News
12.4 QILU
12.4.1 Company Details
12.4.2 Oncology Drugs Product Offered
12.4.3 QILU Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 QILU News
12.5 Sanofi
12.5.1 Company Details
12.5.2 Oncology Drugs Product Offered
12.5.3 Sanofi Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Sanofi News
12.6 HANSOH
12.6.1 Company Details
12.6.2 Oncology Drugs Product Offered
12.6.3 HANSOH Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 HANSOH News
12.7 LUYE
12.7.1 Company Details
12.7.2 Oncology Drugs Product Offered
12.7.3 LUYE Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 LUYE News
12.8 Novartis
12.8.1 Company Details
12.8.2 Oncology Drugs Product Offered
12.8.3 Novartis Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Novartis News
12.9 GuiZhou YiBai
12.9.1 Company Details
12.9.2 Oncology Drugs Product Offered
12.9.3 GuiZhou YiBai Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 GuiZhou YiBai News
12.10 Lunan
12.10.1 Company Details
12.10.2 Oncology Drugs Product Offered
12.10.3 Lunan Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Lunan News
12.11 Eli Lilly and Company

13 Research Findings and Conclusion